Faisal has authored over 1,500 stock specific articles with focus on the technology, energy and commodities sector. for companies whose equities are traded on its platform. These examples also underscore my view that it’s important to have few risky stocks in the core portfolio. Earlier this year, the stock made a 52-week high of $33.79. Despite the recent rally in the stock market, Aurora Cannabis (. ) But is ACB stock a buy today? However, its too early to believe that Aurora Cannabis cannot bounce-back from current headwinds. If I had to consider exposure to China’s e-commerce industry, Alibaba Group (NYSE:BABA) and JD.com (NASDAQ:JD) would be the obvious choices. As of March 2020, the company reported total liquidity of $308.9 million. This is an ongoing effort to support struggling companies like ACB during these challenging economic times. However, with 15 DNA medicine clinical programs currently in development, the future is likely to be exciting. On the other hand, though, small-cap stocks generally have high beta, and can be potential portfolio game-changers. He also hosts a weekly show on YouTube about marijuana stocks. The company’s Q2 2020 revenue surged by 67% as compared to Q2 2019. With an annual dividend payout of 40 cents, the stock has a current dividend yield of 8.25%. As of April 2020, the company reported a total order backlog of $2.1 billion with an average duration of 3.4 years. And as new LNG carriers are delivered, the OCF can potentially double by FY2022. However, my concern is that the company is still reporting losses at an operating level. quotes delayed at least 15 minutes, all others at least 20 minutes. With lower debt and a bright growth outlook, I expect dividends to increase in the coming years. In the recent past, cash burn has been the biggest challenge for the company. In addition, the company had seven LNG carriers under construction. Cannabis stocks have been beaten-down on a sustained basis after March 2019. The company is also in the race for COVID-19 vaccine. With several companies working on vaccine development, this is another potential risk for Inovio Pharmaceuticals. Aurora Cannabis has embarked on a transformation plan that intends to improve profitability and reduce cash burn. In the last six months, the stock has shown positive momentum, having moved higher by 56%. Similarly, Nio (NYSE:NIO) is almost back from the dead when it received funding support earlier this year. Reitmeister Total Return portfolio – Learn Steve Reitmeister’s strategies and current picks that work in bull and bear markets alike. If sales gain traction, EBITDA margin is likely to improve. We applaud the NYSE for their proposal and believe alleviating management from delisting concerns is appropriate. As of this writing, he did not hold a position in any of the aforementioned securities. So with all of that in mind, CMRE stock is likely to trend higher from current levels. Instead they can focus on generating revenues and cutting costs during the coronavirus pandemic. With demand for LNG likely to be robust in emerging Asia for the coming decade, there is ample scope for growth. Now just because a company falls below $1 does not mean that it will be instantly delisted. With the company being a front-runner in the race to produce a vaccine, the stock has surged by 150% in the last six months. 1125 N. Charles St, Baltimore, MD 21201. senior research analyst with 12 years of industry experience in the field of credit research, equity research and financial modelling. Invest in Aurora Cannabis Stock On Tuesday, Aurora Cannabis (NYSE:ACB) announced a potentially massive 1.8 billion CAD ($1.37 billion) write-down for Q4. In addition, the company had $1.25 billion in undrawn credit facility. The company is a leading owner of shipping containers with a fleet of 75 vessels, including five under construction. The company has a net debt-to-EBITDA of 3.39. The company must respond and submit a plan to the NYSE explaining how it will increase the stock price if it wants to remain listed.